 |
Dehydroepiandrosterone (DHEA) |
|---|---|
| Trade Name | Fidelin |
| Orphan Indication | Replacement therapy in individuals with adrenal insufficiency |
| USA Market Approval | USA |
| USA Designation Date | 2003-08-19 00:00:00 |
| Sponsor | Paladin Labs, Inc.;6111 Royalmount Avenue, Suite 102, Montreal;Quebec H4P 2T4 |
